Global Thrombosis Drug Market is expected to grow at a CAGR of 9.63% over the Forecast Period of 2019– 2025
Thrombosis Drugs Market is expected to grow at a CAGR of 9.63% between
2019 and 2025 in terms of value. The various disease conditions treated with
thrombosis drugs include pulmonary embolism, deep vein thrombosis (DVT), and
atrial fibrillation. DVT occurs more commonly in older people. Some researchers
have suggested that there may be a risk from smoking and from varicose veins.
These drugs, also called anticoagulants, are the most common treatment for DVT.
They can keep a clot from growing or breaking off, and they prevent new clots
from forming. But they can't thin your blood, despite their name, or dissolve
an existing clot.
The global thrombosis drug market is primarily driven by the growing prevalence and the increasing awareness of thrombosis. Moreover, the
increasing number of pipeline products and product approvals are expected to
fuel market growth in the near future. However, the High cost of thrombosis
drugs is expected to hinder the demand for the global thrombosis drug market.
Nonetheless, the introduction of novel oral anticoagulants is anticipated to
create a new opportunity for the global thrombosis drug market.